Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.93 CAD -1.68% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

Relative Value

The Relative Value of one CRON stock under the Base Case scenario is 0.41 CAD. Compared to the current market price of 2.93 CAD, Cronos Group Inc is Overvalued by 86%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRON Relative Value
Base Case
0.41 CAD
Overvaluation 86%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
15
Median 3Y
10.7
Median 5Y
13.1
Industry
2.5
Forward
7
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-5.5
Industry
21.9
Forward
-18.9
vs History
12
vs Industry
1
Median 3Y
-8.9
Median 5Y
-10.9
Industry
16.5
vs History
7
vs Industry
Median 3Y
-8.8
Median 5Y
-10.2
Industry
23.6
vs History
77
vs Industry
65
Median 3Y
0.8
Median 5Y
1
Industry
2.1
vs History
vs Industry
81
Median 3Y
0.9
Median 5Y
3.7
Industry
2.6
Forward
-0.5
vs History
vs Industry
41
Median 3Y
-4.4
Median 5Y
-17
Industry
5.2
vs History
12
vs Industry
55
Median 3Y
-0.8
Median 5Y
-2.6
Industry
13.3
Forward
1.4
vs History
12
vs Industry
52
Median 3Y
-0.7
Median 5Y
-2.4
Industry
16.6
Forward
2.4
vs History
vs Industry
18
Median 3Y
-0.6
Median 5Y
-3
Industry
15.6
vs History
vs Industry
35
Median 3Y
-1
Median 5Y
-3
Industry
19.1
vs History
vs Industry
81
Median 3Y
0.2
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

CRON Competitors Multiples
Cronos Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Cronos Group Inc
TSX:CRON
1.1B CAD 7.8 -13.9 0.8 0.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.7B USD 18.3 89.6 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 12.4 35.4 24.6 28.1
US
Johnson & Johnson
NYSE:JNJ
372B USD 4.2 25.3 12.2 15.9
US
Merck & Co Inc
NYSE:MRK
257.3B USD 4.1 21.2 10.7 12.8
CH
Roche Holding AG
SIX:ROG
200.4B CHF 3.4 17.4 9.8 11.7
UK
AstraZeneca PLC
LSE:AZN
162.7B GBP 4.2 31.8 169.5 254
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.1 11.5 10 13.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CA
Cronos Group Inc
TSX:CRON
Average P/E: 33.2
Negative Multiple: -13.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.6
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.4
86%
US
Johnson & Johnson
NYSE:JNJ
25.3
-22%
US
Merck & Co Inc
NYSE:MRK
21.2
7 321%
CH
Roche Holding AG
SIX:ROG
17.4
32%
UK
AstraZeneca PLC
LSE:AZN
31.8
177%
CH
Novartis AG
SIX:NOVN
11.5
21%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top